Drug
Amondys 45
Amondys 45: highest development phase Phase 2, developed by Sarepta Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Sarepta Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Amondys 45 NCT04179409 | Phase 2 | Duchenne Muscular Dystrophy |
Latest
No recent events.
Follow Amondys 45 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.